BCRX FY 2008 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$57M-20.6% YoY

Gross Profit

$57M100.0% margin

Operating Income

-$27M-48.0% margin

Net Income

-$25M-43.7% margin

EPS (Diluted)

$-0.65

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$5.9B

Balance Sheet

Total Assets

$85M

Total Liabilities

$38M

Stockholders' Equity

$46M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$71M	-20.6%
Gross Profit	$57M	$71M	-20.6%
Operating Income	-$27M	-$32M	+15.8%
Net Income	-$25M	-$29M	+14.9%